Cargando…
A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder
BACKGROUND: Anxiety and trauma-related disorders are among the most prevalent and disabling medical conditions in the United States, and posttraumatic stress disorder in particular exacts a tremendous public health toll. We examined the tolerability and anxiolytic efficacy of neuropeptide Y administ...
Autores principales: | Sayed, Sehrish, Van Dam, Nicholas T, Horn, Sarah R, Kautz, Marin M, Parides, Michael, Costi, Sara, Collins, Katherine A, Iacoviello, Brian, Iosifescu, Dan V, Mathé, Aleksander A, Southwick, Steven M, Feder, Adriana, Charney, Dennis S, Murrough, James W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795352/ https://www.ncbi.nlm.nih.gov/pubmed/29186416 http://dx.doi.org/10.1093/ijnp/pyx109 |
Ejemplares similares
-
A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
por: Mathé, Aleksander A, et al.
Publicado: (2020) -
Cortical Transcriptomic Alterations in Association With Appetitive
Neuropeptides and Body Mass Index in Posttraumatic Stress Disorder
por: Stone, Lauren A, et al.
Publicado: (2020) -
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
por: Kiraly, D D, et al.
Publicado: (2017) -
Neuropeptide Y in Alcohol Addiction and Affective Disorders
por: Thorsell, Annika, et al.
Publicado: (2017) -
Resilience in the age of COVID-19
por: Kaye-Kauderer, Halley, et al.
Publicado: (2021)